Ivaltinostat
- Generic Name
- Ivaltinostat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H36N3O8P
- CAS Number
- 936221-33-9
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Machaon Biotherapeutics, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05716919
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- CG Pharmaceuticals, Inc
- Target Recruit Count
- 70
- Registration Number
- NCT05249101
- Locations
- 🇺🇸
Virginia Cancer Specialists, Fairfax, Virginia, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸HonorHealth Medical Center, Scottsdale, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath